StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026Score 9/3079% below fair value
$1.78−0.01 (-0.56%)

Close on Nov 13, 2026Market cap $19.34MP/E –Yield –

Aytu BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Aytu BioPharma's enterprise value was $4.07M on Nov 11, 2026, against $1.38M a year earlier. Over the last 5 years it ranged from -$1.32M to $19.01M, with a median of $8.27M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.07M-25.3%
2025Dec 31, 2025$5.44M-21.1%
2024Dec 31, 2024$6.90M-41.8%
2023Dec 29, 2023$11.86M+367.8%
2022Dec 30, 2022$2.54M-81.7%
2021Dec 31, 2021$13.85M-63.8%
2020Dec 31, 2020$38.27M+267.0%
2019Dec 31, 2019$10.43M–
2018Dec 31, 2018-$2.54M-209.4%
2017Dec 29, 2017$2.32M-30.0%
2016Dec 30, 2016$3.32M-92.4%
2015Dec 31, 2015$43.93M+24233.4%
2014Dec 31, 2014$180.54K-46.0%
2013Dec 31, 2013$334.14K-50.3%
2012Dec 31, 2012$671.89K+102.4%
2011Dec 30, 2011$332.01K–

More Aytu BioPharma figures

See a number that looks wrong?